Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02806791
What this trial is testing

Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

Who this might be right for
Blood Diseases
Azienda Ospedaliera San Giovanni Battista 300
Not applicableStudy completedNCT07663370
What this trial is testing

Effectiveness of Biosimilar Ranibizumab in the Management of Diabetic Macular Edema

Who this might be right for
Anti-VEGF TreatmentRanibizumabBiosimilar
Benha University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05346224
What this trial is testing

Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHER2-positive Breast Cancer
Shanghai Henlius Biotech 900
Large-scale testing (Phase 3)Looking for participantsNCT05696613
What this trial is testing

SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc. 148
Large-scale testing (Phase 3)Study completedNCT02638259
What this trial is testing

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sandoz 376
Large-scale testing (Phase 3)Study completedNCT05338086
What this trial is testing

Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.

Who this might be right for
Postmenopausal Women With Osteoporosis
mAbxience Research S.L. 558
Early research (Phase 1)Study completedNCT02634528
What this trial is testing

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal

Who this might be right for
Diabetes Mellitus
Julphar Gulf Pharmaceutical Industries 85
Testing effectiveness (Phase 2)Looking for participantsNCT07331883
What this trial is testing

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ruijin Hospital 35
Large-scale testing (Phase 3)WithdrawnNCT04254380
What this trial is testing

Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro

Who this might be right for
Diabetes Mellitus, Type 1
Gan and Lee Pharmaceuticals, USA
Post-approval studies (Phase 4)Study completedNCT03819790
What this trial is testing

The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians

Who this might be right for
Diabetes Mellitus, Type 2
LMC Diabetes & Endocrinology Ltd. 119
Not applicableStudy completedNCT02998398
What this trial is testing

Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisCrohn's Disease+1 more
Assistance Publique - Hôpitaux de Paris 262
Early research (Phase 1)Study completedNCT03919448
What this trial is testing

A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab

Who this might be right for
PharmacokineticsSafety Issues
Laboratorios Richmond S.A.C.I.F. 112
Large-scale testing (Phase 3)WithdrawnNCT04466917
What this trial is testing

ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-small Cell Lung Cancer (NSCLC)Non-squamous NSCLC
Amgen
Early research (Phase 1)Study completedNCT04238650
What this trial is testing

A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male Volunteers

Who this might be right for
Healthy VolunteersMaleJapanese
mAbxience Research S.L. 49
Post-approval studies (Phase 4)Study completedNCT02148640
What this trial is testing

The NOR-SWITCH Study

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis+3 more
Diakonhjemmet Hospital 482
Not applicableStudy completedNCT03885089
What this trial is testing

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

Who this might be right for
Psoriasis VulgarisPsoriasis ArthropathicaPustular Psoriasis+1 more
Pfizer 10
Large-scale testing (Phase 3)Study completedNCT06497491
What this trial is testing

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

Who this might be right for
Still's Disease Adult Onset
AO GENERIUM 118
Early research (Phase 1)Not Yet RecruitingNCT07606521
What this trial is testing

A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus

Who this might be right for
Multiple Sclerosis
Polpharma Biologics International AG 222
Not applicableStudy completedNCT04841187
What this trial is testing

Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis

Who this might be right for
Psoriasis
Assistance Publique - Hôpitaux de Paris 2,000
Large-scale testing (Phase 3)Study completedNCT05843916
What this trial is testing

Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease

Who this might be right for
Fabry Disease
Bio Sidus SA 20
Next Page